Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9600
+0.1227 (14.65%)
At close: Apr 15, 2026, 4:00 PM EDT
0.9800
+0.0200 (2.08%)
After-hours: Apr 15, 2026, 7:41 PM EDT

RANI Revenue

In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth. Rani Therapeutics Holdings had revenue of $1.46M in the quarter ending December 31, 2025, with 42.12% growth.

Revenue (ttm)
$1.63M
Revenue Growth
+58.85%
P/S Ratio
58.62
Revenue / Employee
$23,000
Employees
71
Market Cap
95.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.63M605.00K58.85%
Dec 31, 20241.03M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 20212.72M2.26M488.10%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortress Biotech63.26M
Champions Oncology57.95M
Q32 Bio53.74M
Pelthos Therapeutics16.80M
NeurAxis3.57M
iBio, Inc.300.00K
aTyr Pharma190.00K
InflaRx34.44K
Revenue Rankings